Vaccines

Adjuvant Capital is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public health challenges. It focuses on historically overlooked market segments, leveraging expertise to translate opportunities into social and financial returns. The firm's investment model is heavily influenced by global trends such as climate change and antimicrobial resistance.

Advent Life Sciences is a leading trans-Atlantic venture capital firm focused on building innovative Life Sciences businesses. They invest in early and mid-stage companies with a first-in-class or best-in-class approach, turning breakthrough science into approved medicines or medical products. The firm takes a hands-on approach, working closely with management teams to achieve superior financial returns.

Sanofi Ventures is the corporate venture capital arm of Sanofi. They invest in top-tier biotech and digital health companies focusing on improving patient care and transforming healthcare. Their investments span from Seed to Series B and beyond, offering portfolio companies access to Sanofi's expertise.